Background illustration for clinical trials search

Paid Clinical Trials Syracuse

Discover 243 paid clinical trials in Syracuse, New York. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer

for
Non-muscle Invasive Bladder Cancer
Location: Syracuse NY, Rochester NY, Toronto, The Bronx NY,
Sponsor: Protara Therapeutics

Sex: All

Age: 18+

Code: NCT05951179

Phase2, Recruiting

Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer

for
Metastatic Prostate Cancer
Location: Syracuse NY, Long Island City NY, New Haven CT,
Sponsor: Janssen Research & Development, LLC

Sex: Male

Age: 18+

Code: NCT06800313

Phase1, Phase2, Recruiting

An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.

for
Oligometastatic Prostate Cancer (OMPC)
Location: Syracuse NY, Ottawa, Toronto, The Bronx NY, New York NY,
Sponsor: Novartis Pharmaceuticals

Sex: Male

Age: 18 - 70+

Code: NCT05939414

Phase3, Recruiting

Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") Patients

for
Non-Muscle Invasive Bladder Cancer ("NMIBC") Unresponsive/Intolerant to BCG,
Location: Syracuse NY, Toronto, Hamilton, Montreal, London,
Sponsor: Theralase® Technologies Inc.

Sex: All

Age: 18+

Code: NCT03945162

Phase2, Recruiting

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

for
Superficial Bladder Cancer,
Location: Syracuse NY, Albany NY, Buffalo NY, Toronto,
Sponsor: enGene, Inc.

Sex: All

Age: 18+

Code: NCT04752722

Phase1, Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Phase 2A/B Efficacy and Safety of Dabogratinib in Participants With Low Grade Upper Tract Urothelial Carcinoma

for
Low Grade Upper Tract Urothelial Carcinoma
Location: Syracuse NY, Albany NY, Radnor PA, Sewell NJ,
Sponsor: Tyra Biosciences, Inc

Sex: All

Age: 18+

Code: NCT07265947

Phase2, Recruiting

Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC

for
Prostate Cancer
Location: Syracuse NY, Cooperstown NY, Rochester NY, The Bronx NY,
Sponsor: Novartis Pharmaceuticals

Sex: Male

Age: 18 - 70+

Code: NCT06855277

Phase3, Recruiting

A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer

for
Non-Muscle Invasive Bladder Neoplasms
Location: Syracuse NY, Lancaster PA, Bala-Cynwyd PA,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06919965

Phase3, Recruiting

Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy

for
Prostate Cancer
Location: Syracuse NY, The Bronx NY, Hartford CT, Philadelphia PA,
Sponsor: Novartis Pharmaceuticals

Sex: Male

Age: 18 - 70+

Code: NCT06780670

Phase2, Phase3, Recruiting

Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T

for
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Location: Syracuse NY, North Hills NY, Lancaster PA,
Sponsor: Dendreon

Sex: Male

Age: 18+

Code: NCT06134232

Phase2, Recruiting

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

for
Metastatic Castration-resistant Prostate Cancer (mCRPC),
Location: Syracuse NY, Ottawa, Toronto, Mississauga,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06136650

Phase3, Recruiting

AI-Assisted Treatment for Residual Speech Sound Disorders

for
Speech Sound Disorder
Location: Syracuse NY
Sponsor: Syracuse University

Sex: All

Age: 9 - 17

Code: NCT05988515

Recruiting

Intensive Speech Motor Chaining Treatment for Residual Speech Sound Disorders

for
Speech Sound Disorder
Location: Syracuse NY
Sponsor: Syracuse University

Sex: All

Age: 9 - 17

Code: NCT05929859

Phase1, Phase2, Recruiting

Acceptance and Commitment Therapy for HIV+ Hazardous Drinkers

for
HIV-1-infection, Alcohol Drinking
Location: Syracuse NY
Sponsor: Syracuse University

Sex: All

Age: 18+

Code: NCT06648629

Recruiting

Visual-acoustic Intervention With Service Delivery In-person and Via Telepractice Trial

for
Speech Sound Disorder
Location: Syracuse NY, Bloomfield NJ
Sponsor: New York University

Sex: Female

Age: 9 - 17

Code: NCT06517225

Phase2, Recruiting

Effects of HIIT vs. TRE on Type 2 Diabetes Risk

for
Obesity and Type 2 Diabetes, Metabolic Diseases,
Location: Syracuse NY
Sponsor: Syracuse University

Sex: All

Age: 14 - 30

Code: NCT07215533

Recruiting

Treatment for /s/ Production Errors in Children With Speech Sound Errors

for
Speech Sound Disorder
Location: Syracuse NY
Sponsor: Syracuse University

Sex: All

Age: 7 - 11

Code: NCT07214480

Recruiting

Brain Stimulation Effects on Post-Stroke Fatigue and Aphasia

for
Aphasia Following Cerebral Infarction, Stroke Ischemic,
Location: Syracuse NY
Sponsor: Syracuse University

Sex: All

Age: 18+

Code: NCT07151677

Recruiting

Generalization With AI Navigation Using StaRt

for
Speech Sound Disorder
Location: Syracuse NY, Bloomfield NJ
Sponsor: New York University

Sex: All

Age: 9 - 17

Code: NCT06884943

Phase2, Recruiting

A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE

for
Lupus Erythematosus, Systemic
Location: Syracuse NY, New York NY, Boston MA, Chapel Hill NC,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70

Code: NCT06897930

Phase1, Phase2, Recruiting